US Stem Cell Inc (USRM)

[Dragon Lady]

BHRT MARKET CAP has COLLAPSED approx 90% since IPO to TODAY:

When a company sells shares in an IPO, it does not sell the entire company O/S share count? A large part of BHRT at the time of the IPO was held by insiders and also at that time- PRIVATE INVESTORS. The market cap estimates at the time of the IPO were much, much, much higher in 2008 and have since massively collapsed (to recently below $5 million, dipping as low as about $3 million recently).

Here is various PR coverage by firms, then, covering the BHRT IPO and stating what the estimated market cap would be after the public offering- based on the company's then total share count X price after offering. And it wasn't anywhere close to as low as $5 million, not by a long shot.

http://www.nasdaq.com/markets/ipos/company/bioheart-inc-734841-53406

That's the Nasdaq page itself- and shows then approx 14 MILLION shares outstanding at the time of the IPO. That would have put the market cap at approx 14 X 5 = $70 million at time of the IPO. Meaning the market cap has now collapsed by approx 90% or more (as the common share price has collapsed by a literal 99.99% since the IPO)

And a final analysis done after the dismal IPO in an article written by a firm that tracks and covers IPO's:

http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/

Notice, it states (at the time of Feb 2008, just after the dismal IPO):

"Leonhardt, by the way, now owns just over 32 percent of the company, a holding worth about $24 million at Bioheart’s current valuation. Ms. Farley, meanwhile, exercises control over a 3.4 percent stake in the post-IPO company, now worth about $2.5 million."

If Leonhardt owned 32% of the company post IPO and that stake was worth about $24 million then (remember, it RAPIDLY collapsed post IPO, within only months, the stock chart is a straight down ski slope, for all intents and purposes) then the MARKET CAP on Feb 19, 2008 WAS ABOUT 3 X $24 million = $72 MILLION and NOT THE SUPPOSED $5 MILLION CLAIMED HERE. WRONG. The market cap has COLLAPSED MASSIVELY BY APPROX. 90% OR MORE SINCE THE IPO, from about $70 MILLION in 2008 to about $5 MILLION OR LESS TODAY, SIMPLE AS THAT.

AND, that massive collapse in market cap has occurred despite the enormous, massive share dilution from then, 2008, having approx 15 MILLION shares outstanding (O/S shares) to approx 30 MILLION shares O/S in mid 2010 when the present CEO took over (CEO number 3 or 4 since being a public company: Leonhardt, Groth and Pinon in 2007 and now Tomas since June or so of 2010) to now approx 700 MILLION shares dilution and rapidly climbing under CEO Tomas. Tomas from mid 2010 to today- took the O/S share count from approx. 30 million to blowing through the 700 MILLION mark today, and NO major clinical trials have occurred or advanced since the 2009/2010 time period (see any prior SEC 10-K filing).